In an effort to determine the value of phytoestrogens in clinical practice, Austrian researchers analyzed six systematic reviews and meta-analyses of 25 randomized, controlled trials (RCTs).
In an effort to determine the value of phytoestrogens in clinical practice, Austrian researchers analyzed six systematic reviews and meta-analyses of 25 randomized, controlled trials (RCTs).
Generally, they found the results contradictory and the findings of the meta-analyses to demonstrate no statistically significant reduction in vasomotor symptoms. However, one systematic review of five RCTs found that in a select population of women-those in early and natural postmenopause with mild-to-moderate vasomotor symptoms-five out of the five studies found a significant reduction in hot flashes. And a meta-analysis of 21 studies found a significantly reduced risk of breast cancer in past users of phytoestrogens.
While various RCTs report favorable effects on bone mineral density, vasodilation, platelet aggregation, insulin resistance, and serum concentrations of triglycerides, high-density lipoprotein, and low-density lipoprotein, no study proves an actual protective effect against the endpoints of breast cancer, bone fracture, or cardiovascular events.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More